Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 9.90 is 24% above its 5-year average of 7.99, around the middle of its 5-year range (0.02–25.58).
As of the fiscal period ended Tuesday, March 31, 2026. 5.18% above its 12-month average of 9.41.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2026 (2026-03-31): 9.90.
QUICK RATIO (ACID-TEST)
9.90
QUICK RATIO (ACID-TEST) AVG TTM
9.41
QUICK RATIO (ACID-TEST) AVG 3Y
11.88
QUICK RATIO (ACID-TEST) AVG 5Y
7.99
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+5.18%
CURRENT VS 3Y AVG
-16.67%
CURRENT VS 5Y AVG
+23.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+195.03%
vs the sector median at left
Virax Biolabs Group Limited
Market Cap
$378849.00
Quick Ratio (Acid-Test)
9.90
TTM Avg
9.41
3Y Avg
11.88
5Y Avg
7.99
Market Cap
$403887.00
Quick Ratio (Acid-Test)
0.78
TTM Avg
0.50
3Y Avg
0.69
5Y Avg
2.39
Market Cap
$481786.00
Quick Ratio (Acid-Test)
3.59
TTM Avg
2.57
3Y Avg
4.32
5Y Avg
8.01
Market Cap
$250443.00
Quick Ratio (Acid-Test)
2.38
TTM Avg
3.83
3Y Avg
3.05
5Y Avg
3.34
Market Cap
$518606.00
Quick Ratio (Acid-Test)
1.70
TTM Avg
2.81
3Y Avg
3.06
5Y Avg
14.47
Market Cap
$545796.00
Quick Ratio (Acid-Test)
0.06
TTM Avg
0.15
3Y Avg
3.02
5Y Avg
6.94
Market Cap
$110112.00
Quick Ratio (Acid-Test)
0.94
TTM Avg
1.53
3Y Avg
2.70
5Y Avg
2.29
Market Cap
$95475.00
Quick Ratio (Acid-Test)
8.09
TTM Avg
12.83
3Y Avg
6.46
5Y Avg
13.37
Market Cap
$667469.00
Quick Ratio (Acid-Test)
7.25
TTM Avg
5.33
3Y Avg
3.37
5Y Avg
2.65
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Virax Biolabs Group Limited (VRAX) | $378849.00 | 9.90 | 9.41 | 11.88 | 7.99 |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | 0.78 | 0.50 | 0.69 | 2.39 |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | 3.59 | 2.57 | 4.32 | 8.01 |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | 2.38 | 3.83 | 3.05 | 3.34 |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | 1.70 | 2.81 | 3.06 | 14.47 |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | 0.06 | 0.15 | 3.02 | 6.94 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | 0.94 | 1.53 | 2.70 | 2.29 |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | 8.09 | 12.83 | 6.46 | 13.37 |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | 7.25 | 5.33 | 3.37 | 2.65 |
| PRF Technologies Ltd. (PRFX)vs › | $70884.00 | 5.07 | 1.79 | 2.96 | 8.89 |
Quick Ratio
9.90
Excludes inventory
Current Ratio
9.97
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 9.90 |
| 2025-09-30 | 11.21 |
| 2025-03-31 | 7.13 |
| 2024-09-30 | 11.20 |
| 2024-03-31 | 25.58 |
| 2023-09-30 | 7.56 |
| 2023-03-31 | 10.58 |
| 2022-09-30 | 4.64 |
| 2022-03-31 | 0.02 |
| 2021-09-30 | 0.02 |
| 2021-03-31 | 0.02 |
| 2020-09-30 | 0.00 |
| 2020-03-31 | 0.02 |
| 2019-09-30 | 0.00 |
